Letrobol 2.5 (Letrozole USP 2.5mg) is an oral aromatase inhibitor. It works by significantly decreasing estrogen production in the body. Primarily prescribed as a breast cancer treatment, it is also utilized off-label to stimulate ovulation.
Enfiera 500mg Injection is a targeted monoclonal antibody (Rituximab) that treats specific cancers and severe autoimmune diseases by depleting overactive or malignant B-cells. It is primarily used in oncology and rheumatology to inhibit disease progression and manage inflammation.
| Active Ingredient | Rituximab |
| Drug Class | Anti-CD20 Monoclonal Antibody |
| Therapeutic Area | Oncology (Blood Cancers), Immunology, Rheumatology |
| Dosage Form | Intravenous (IV) Injection / Infusion (50ml vial) |
| Shelf Life | 36 months |
| Strength | 500 mg |